Jean-François Aliotti

Bioxel Pharma, Inc. develops pharmaceutical products used in the treatment of cancer, multiple sclerosis and Alzheimers. The company is engaged in the development, production and distribution of therapeutically active taxanes isolated from the Canadian yew. Bioxel Pharma was founded on July 13, 1995 and is headquartered in Quebec, Canada.

Verlingue SAS provides insurance brokerage services. Its solutions include employee benefits, property damage, business interruption, liabilities, motor fleets, building trade, transportation, and payment protection. The company was founded in 1933 and is headquartered in Quimper, France.

Axovan AG conducts biopharmaceutical research and develops pharmaceuticals. Active in pharmaceutical research and development, it focuses on the family of drug targets called G protein-coupled receptors (GPCRs), which are involved in a number of pathologies. It has developed a validated GPCR-based chemical library through its proprietary chem-informatics platform AXADDIS. Its lead product, clasozentan, is an intravenous endothelin receptor antagonist optimized for treating cerebral diseases. It is partnering non-core indication projects (pain, metabolic diseases, inflammation) at earlier stages. The company was founded in 2000 and is headquartered in Allschwil, Switzerland.

GO Capital SAS (GO Capital) is an independent French private equity firm founded 2003 and is headquartered in Saint-Jacques-de-la-Lande. Formerly known as Grand Ouest Gestion SAS, the firm's investors include regional and cooperative banks, Natixis and CDC PME.GO Capital is located in Rennes and focuses primarily on the northwest quarter of France, also known as Grand Ouest, which comprises the Brittany, Poitou-Charentes, Pays de la Loire and Basse Normandie regions. The firm manages the Ouest Ventures fund.

BPIFrance Investissement SAS (BPIfrance Investissement) is the private equity arm and subsidiary of State-owned Banque Publique d'Investissement in France. Formerly known as CDC Entreprises SAS, the firm was established in 1994 to carry out public-interest missions such as employment creation and momentum initiation in the private equity field. In 2013 they became BPIfrance Investissement when CDC Entreprises, FSI and FSI Régions merged. Headquartered in Paris, BPIfrance Investissement invests of behalf of the Government of France, as well as for third parties including FEI-Fonds Européen d'Investissement, BEI-Banque Européenne d'Investissement and BPCE SA. The firm invests directly or indirectly in SMEs and intermediate-sized companies at all stages of their development.

Endeavour Vision SA (EV) is an independent venture capital firm headquartered in Geneva. EV traces their origins back to 1989 through the convergence of the Vision Capital European team and the Swiss VC firm, Endeavour. EV was co-founded in 2000 by Sven Lingjaerde and Damien Tappy. The firm specializes in providing funding for entrepreneurs in life sciences, biotech, medtech, cleantech and information technology. EV operates in close cooperation with Genevest, an independent investment vehicle which has reached the divestment stage. Their investors in the funds they advise are industrial corporations, family offices, global institutional investors and business leaders in the technology and investment industry.

OncoEthix SA operates as a clinical stage biotechnology company which develops cancer drugs. Its products include OTX008, OTX015, and OTX009. The company was founded by Esteban Cvitkovic, Jeanne Kay Noel, Yves Paternot, and Patrice Herait in March 2007 and is headquartered in Luzern, Switzerland.

AstraZeneca SAS researches, develops, produces, and commercializes pharmaceutical products. It offers solutions in different domains such as cardio-vascular, metabolism, oncology, respiratory, and inflammatory diseases. The company was founded on April 21, 1955 and is headquartered in Courbevoie, France.

Minka Therapeutics SA develops therapeutic products and diagnostic complementary to current antiretroviral therapy in the treatment of AIDS. The firm provides therapeutic and diagnostic solutions for diseases linked to the immune system through its research on immune dysregulations. The company was founded by Patrice Debre, Vincent Vieillard, Michel Klein, Joël Crouzet, and Robert L. Murphy in 2008 and is headquartered in Evry, France.

Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE.

Millendo Therapeutics SAS provides pharmaceutical research services. It engages in the development of biopharmaceutical drugs, proteins and peptides for the treatment of metabolic diseases and rare diseases. The company was founded by Thierry Abribat, André de Villers, Ezio Ghigo and Aart Jan van der Lely on April 23, 2007 and is headquartered in Ecully, France.

Biogen France SAS engages in research and development of biotechnology. The company was founded in 1994 and is headquartered in Paris, France.

Thales Security Solutions & Services SAS designs and assembles industrial process control equipment. The company is based in Vélizy-Villacoublay, France. The French company is ultimately controlled by the Government of France.

Foroil SAS engages in designing, selling solutions and services indirectly or directly linked to exploiting oil and gas fields. It provides production forecasts and development scenarios for hydrocarbon field's time. The firm's products include ProductionForecaster, FieldDevelopmentEngine, and myField. The company was founded by Hugues de Saint Germain, Jean-Marc Oury, and Bruno Heintz in 2007 and is headquartered in Paris, France.

Part of Applied Materials, Inc., Applied Materials UK Ltd. is a leader in materials engineering solutions for the semiconductor, flat panel display, and solar photovoltaic industries. The company was founded in 1980 and is based in Reading, UK. Applied Ventures, LLC, the venture capital arm of Applied Materials, Inc., invests in innovative startups. Applied Materials offers a range of supply chain services to keep tools and fabs operating at peak performance, including transactional spares, expert rebuilds, and forecasted parts management. The British company's fully optimized parts network supports the added complexity of today's and tomorrow's semiconductor and display.

Groupe hospitalier Pitié-Salpêtrière is a part of the AP-HP, which is the CHU of Ile-de-France and is based in Paris, France. The AP-HP has 38 hospitals that receive 8.3 million patients every year. The French company provides medical, social, and legal support to victims of violence through its Maison des Femmes program. The private company also has several research chairs in different fields and all of its clinical services are subject to regulatory certification by the Haute Autorité de Santé (HAS). The company uses indicators to regularly evaluate the quality and safety of the care it provides. The company also has a team of social workers who can help patients with their needs outside of the hospital. The company has protocols for cooperation between healthcare professionals to extend the scope of activities of paramedics while ensuring the quality and safety of care.

Part of Grünenthal Pharma GmbH & Co. KG, Mestex AG is a Swiss pharmaceutical manufacturing company. The company is based in Basel, Switzerland. The CEO of the company is Olivier Valdenaire. Mestex was acquired by Grünenthal GmbH on April 12, 2021.

Life Biosciences, Inc. engages in the provision of research on aging and age-related diseases. It focuses on altered communication and inflammation, chromosomal instability, cellular senescence, loss of protoeostasis, metabolism, stem cell exhaustion, epigenetic alterations, and mitochondrial dysfunction. The company was founded by David Sinclair and Tristan Alexander Edwards in 2017 and is headquartered in Boston, MA.

Igyxos SA engages in the development of an innovative medical and pharmaceutical technologies in the field of human fertility. It is involved in all phases of development, from the discovery of promising targets to the identification of potential lead compounds. The company was founded by Marie-Christine Maurel and is headquartered in Nouzilly, France.